Brain Pizza • 662 implied HN points • 22 Oct 24
- New diabetes drugs, like GLP-1 agonists, may help reduce cravings for alcohol and opioids. This suggests they could be useful for treating substance use disorders.
- These medications were originally designed for weight loss and diabetes management, but they are showing potential in other areas of health.
- The findings from recent studies hint at a broader impact of these drugs, which could change how we approach treatment for various health conditions, not just diabetes.